×
To start your customized experience click the start button
Customize
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Prostate

Feature Video
Receiving a diagnosis of prostate cancer can be frightening and confusing. Understanding the details of your specific cancer and how they relate to your prognosis and treatment planning is an important first step toward shared decision-making between you and your physicians. In these CURE Connections programs you will learn the meaning of the PSA test, prostate cancer staging and grading, and how these factors are used to determine which treatment approach is right for you. Management of prostate cancer related symptoms, available treatments, and how to deal with side effects are also discussed. In addition, you will hear from patients and caregivers about their personal experiences with prostate cancer.
Kristie L. Kahl
Data from a pilot study showed an added benefit from the incorporation of extra virgin olive oil into the diets of men with low-risk prostate cancer. As a result, this dietary modification could lead to weight loss, while also helping the body to absorb compounds with anticancer properties.
 
Ariela Katz
A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects.
Ariela Katz
After a drop, the frequency of PSA screening for prostate cancer has stabilized.
Ariela Katz
Study: To prolong survival in early-stage prostate cancer that is low-risk, observe instead of operating.
Ariela Katz
A targeted drug for women with ovarian cancer may also benefit men with prostate cancer who have similar genetic mutations. A phase 3 trial is designed to find out.
Jason Harris
Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen.
Erik Ness
Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive.
Mindy Waizer
Stroke survivors were diagnosed with cancer at almost double the rate of incidence in the general population, one study showed.
Mathew Shanley
Hall of Fame quarterback Jim Kelly met with CURE to talk about his cancer experience.
Brielle Urciuoli
For years, people believed that there was a link between vasectomies and prostate cancer.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable